AU3167095A - Pth or pthrp antagonists - Google Patents

Pth or pthrp antagonists

Info

Publication number
AU3167095A
AU3167095A AU31670/95A AU3167095A AU3167095A AU 3167095 A AU3167095 A AU 3167095A AU 31670/95 A AU31670/95 A AU 31670/95A AU 3167095 A AU3167095 A AU 3167095A AU 3167095 A AU3167095 A AU 3167095A
Authority
AU
Australia
Prior art keywords
pth
pthrp
antagonists
pthrp antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31670/95A
Inventor
Francois Cardinaux
Jean Honore M. Feyen
Rainer Gamse
Frank Otto Gombert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415255A external-priority patent/GB9415255D0/en
Priority claimed from GB9415254A external-priority patent/GB9415254D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU3167095A publication Critical patent/AU3167095A/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Amend patent request/document other than specification (104) Assignors: SANDOZ LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31670/95A 1994-07-28 1995-07-27 Pth or pthrp antagonists Abandoned AU3167095A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9415255A GB9415255D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415254 1994-07-28
GB9415254A GB9415254D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415255 1994-07-28
PCT/EP1995/002993 WO1996003437A1 (en) 1994-07-28 1995-07-27 PTH OR PTHrP ANTAGONISTS

Publications (1)

Publication Number Publication Date
AU3167095A true AU3167095A (en) 1996-02-22

Family

ID=26305357

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31670/95A Abandoned AU3167095A (en) 1994-07-28 1995-07-27 Pth or pthrp antagonists

Country Status (15)

Country Link
EP (1) EP0773958A1 (en)
JP (1) JPH10502091A (en)
AU (1) AU3167095A (en)
BR (1) BR9508433A (en)
CA (1) CA2192787A1 (en)
CO (1) CO4410206A1 (en)
CZ (1) CZ23397A3 (en)
FI (1) FI970168A0 (en)
HU (1) HUT77979A (en)
IL (1) IL114736A0 (en)
NO (1) NO970356L (en)
PL (1) PL318017A1 (en)
SK (1) SK12097A3 (en)
TR (1) TR199500915A2 (en)
WO (1) WO1996003437A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW505654B (en) * 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
AU3819497A (en) * 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs
EP0962467A4 (en) 1996-09-26 2002-10-30 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
JP2001517957A (en) 1997-05-14 2001-10-09 アヴェンティス ファーマシューティカルズ プロダクツ インコーポレイテッド Peptide parathyroid hormone analogs
ATE361099T1 (en) * 1997-05-15 2007-05-15 Chugai Pharmaceutical Co Ltd REMEDIES FOR CACHEXIA
CA2373885A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for diseases caused by pth or pthrp
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
CA2373945A1 (en) * 1999-07-06 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Remedies for drug-resistant hypercalcemia
WO2001021198A1 (en) * 1999-09-20 2001-03-29 Eli Lilly And Company Method for reducing the risk of cancer
WO2001054725A1 (en) * 2000-01-25 2001-08-02 Chugai Seiyaku Kabushiki Kaisha Remedies and preventives for dental diseases
WO2001064249A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue decomposition inhibitor
EP1283057B2 (en) 2000-04-28 2012-05-30 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors
EP1849479A1 (en) * 2000-08-16 2007-10-31 Chugai Seiyaku Kabushiki Kaisha Ameliorating agent for symptoms resulting from joint diseases
MX353986B (en) 2007-08-01 2017-11-06 Massachusetts Gen Hospital Screening methods using g-protein coupled receptors and related compositions.
MX358161B (en) 2010-05-13 2018-08-06 The General Hospital Corp Star Parathyroid hormone analogs and uses thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH05509098A (en) * 1990-07-13 1993-12-16 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア Parathyroid hormone analogs modified in position 3, 6 or 9
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments

Also Published As

Publication number Publication date
SK12097A3 (en) 1997-08-06
IL114736A0 (en) 1995-11-27
NO970356D0 (en) 1997-01-28
FI970168A (en) 1997-01-15
BR9508433A (en) 1998-07-14
CO4410206A1 (en) 1997-01-09
JPH10502091A (en) 1998-02-24
HUT77979A (en) 1999-01-28
TR199500915A2 (en) 1996-06-21
CA2192787A1 (en) 1996-02-08
MX9700446A (en) 1998-06-28
WO1996003437A1 (en) 1996-02-08
FI970168A0 (en) 1997-01-15
EP0773958A1 (en) 1997-05-21
PL318017A1 (en) 1997-05-12
NO970356L (en) 1997-01-28
CZ23397A3 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU2356495A (en) Chemical feeder
AU4036895A (en) Substituted 1H-imidazoles
ZA9610858B (en) Heteroclyclic compounds.
HU9601176D0 (en) Adhesion-receptor antagonists
AU3190495A (en) Transmitter-receiver
AU3994995A (en) Sprayer
AU6856796A (en) Des-arg9-bk antagonists
AU3567195A (en) Neurokinin antagonists
AU3167095A (en) Pth or pthrp antagonists
AU2844595A (en) Substituted biphenyloxazolines
HU9503191D0 (en) Adhesion-receptor antagonists
AU3554995A (en) Antipicornaviral agents
AU1574995A (en) Tachykinins antagonists
ZA964560B (en) Anit-viral compounds.
AU3856295A (en) Endothelin antagonists
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
AU2053399A (en) Inductive component
AUPN725095A0 (en) The backstrap
AUPM701694A0 (en) Improved biocide
ZA967181B (en) Substituted Benzylaminopiperidine Compounds.
AUPN439995A0 (en) Improved biocide
AU131279S (en) Construction component
AUPM614194A0 (en) The lovescent bowl
AUPN000894A0 (en) The bath